Diabetes and weight loss drugs may also boost mental well-being, study finds
A major new study from King’s College London suggests that medications used to treat diabetes and obesity may also help improve emotional health.
These drugs,...
Even ‘less healthy’ plant foods help diabetics lose weight, study show
A new study has found that people with type 1 diabetes can lose weight by switching from animal-based foods to plant-based ones—even when the...
Waist size compared to height may predict future heart failure better than BMI
A new study suggests that your waist size in relation to your height may be a stronger warning sign for future heart failure than...
New study finds the key to fighting obesity and diabetes
Scientists at Sweden's Karolinska Institutet have discovered a promising new way to tackle obesity and its related conditions like fatty liver disease and type...
New drug shows promise for heart health in overweight people
A new study has found that a drug called semaglutide could help improve heart health in people who are overweight or obese, even if...
New pill offers hope for diabetes and obesity treatment
Researchers at the University of Adelaide have made a breakthrough in the fight against type 2 diabetes and obesity. They have developed a pill...
Nature’s Ozempic: What and how you eat can increase levels of GLP-1 without drugs
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without...
Collagen-enriched protein bars may help you lose weight
New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Nutrients suggests that collagen-enriched protein bars could be a safe,...
Waist-to-height ratio can predict heart failure, study finds
A new study has found that the waist-to-height ratio (WtHR) could be a better way to predict heart failure than the commonly used body...
This drug can rapidly lower heart attack risk in people with obesity
New research presented at the European Congress on Obesity (ECO25) in Malaga, Spain, reveals that semaglutide, a medication originally designed for type 2 diabetes,...